%0 Journal Article
%T Cardiac amyloidosis red flags: What all the cardiologist have to know.
%A Maloberti A
%A Ciampi C
%A Politi F
%A Fabbri S
%A Musca F
%A Giannattasio C
%J Int J Cardiol Cardiovasc Risk Prev
%V 21
%N 0
%D 2024 Jun
%M 39118988
暂无%R 10.1016/j.ijcrp.2024.200271
%X Cardiac amyloidosis is becoming increasingly important among cardiologist and an early diagnosis is very important. Amyloidosis is a systemic disease and many cardiac and extracardiac elements (red flags) should raise the suspicion of the disease. Electrocardiographic and imaging techniques (such as echocardiography, cardiac magnetic resonance and scintigraphy) are useful tools to make a diagnosis together with the presence of orthopedic issues, peripheral neuropathy or plasma cell dyscrasia. Cardiac amyloidosis is also often associated with valvular disorder, heart failure or cardiomyopathy. Red flags are crucial to raise suspicion and reach an early diagnosis, in order to start a targeted treatment strategy that could change the patient's outcome. Indeed, in the last years four new drugs were approved to treat transthyretin amyloidosis.